Valuation: Abbott Laboratories (Pakistan) Limited

Market Cap 89.8B 323M 280M 261M 240M 453M 30.8B 464M 3.08B 1.21B 15.36B 1.21B 1.19B 51.35B P/E 2024
23.2x
P/E 2025 -
Enterprise Value 89.8B 323M 280M 261M 240M 453M 30.8B 464M 3.08B 1.21B 15.36B 1.21B 1.19B 51.35B EV / Sales 2024
-
EV / Sales 2025 -
Free-Float
19.95%
Yield 2024 *
-
Yield 2025 3.81%
1 day+0.19%
1 week-0.18%
1 month-6.82%
3 months+3.94%
6 months-20.54%
Current year-12.66%
1 week 910.25
Extreme 910.25
944
1 month 905.1
Extreme 905.1
1,029
Current year 821
Extreme 821
1,274
1 year 821
Extreme 821
1,304
3 years 330
Extreme 330
1,310
5 years 330
Extreme 330
1,310
10 years 302.1
Extreme 302.1
1,310
Manager TitleAgeSince
Chief Executive Officer - 31/03/2016
Director of Finance/CFO - 31/10/2019
Chief Operating Officer - 31/05/2024
Director TitleAgeSince
Director/Board Member - 28/02/2009
Director/Board Member - 03/06/2014
Chairman - 29/05/2022
Change 5-day change 1-year change 3-year change Capi.($)
+0.19%-0.18%-15.12%+133.28% 323M
-0.53%-3.95%+55.23%+152.74% 1,024B
+0.21%-2.68%+55.61%+53.02% 618B
-2.51%-3.25%+32.76%+67.76% 443B
+0.06%-0.42%+37.53%+30.67% 349B
-0.14%-0.24%+34.41%+39.01% 297B
-0.69%-0.30%+11.55%+12.93% 264B
-7.37%-4.40%-2.54%-43.87% 209B
-0.64%+2.43%+30.52%+64.49% 208B
-0.82%+0.70%+15.96%+71.01% 162B
Average -1.22%-1.29%+25.59%+58.10% 357.41B
Weighted average by Cap. -0.99%-1.93%+39.23%+72.96%

Financials

2024 2025
Net sales 68.18B 246M 213M 198M 182M 344M 23.38B 353M 2.34B 917M 11.66B 922M 902M 38.99B 75.4B 272M 235M 219M 201M 381M 25.86B 390M 2.58B 1.01B 12.9B 1.02B 997M 43.12B
Net income 5.23B 18.85M 16.35M 15.23M 13.99M 26.43M 1.8B 27.07M 179M 70.43M 895M 70.78M 69.22M 2.99B 7.97B 28.69M 24.88M 23.17M 21.29M 40.23M 2.73B 41.2M 273M 107M 1.36B 108M 105M 4.56B
Net Debt - -
Logo Abbott Laboratories (Pakistan) Limited
Abbott Laboratories Pakistan Limited is engaged in the manufacture, import and marketing of branded generic pharmaceutical, nutritional, diagnostic, diabetes care, molecular devices, hospital, and consumer products. The Company operates through four segments: Pharmaceutical, Nutritional, Diagnostic, and Others. It offers treatment options for a number of areas, including the digestive system, heart health, women’s health, respiratory illness, central nervous system/pain and influenza vaccines. Its nutritional brands include Similac, PediaSure, Pedialyte, Ensure, and Glucerna. It offers tests and diagnostic tools, medical diagnostic instruments, automation and informatics solutions for hospitals, reference labs, blood centers, emergency departments, physician offices and clinics. The Company’s easy-to-use test strips require only tiny blood samples while its meters provide results and reports.
Employees
1,380
Date Price Change Volume
31/07/26 PKR 917.23 +0.19% 4,861
30/07/26 PKR 915.48 -0.93% 8,760
29/07/26 PKR 924.12 -1.15% 4,874
28/07/26 PKR 934.91 -0.29% 2,437
27/07/26 PKR 937.59 +2.04% 27,285
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
917.23
Average target price
-

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ABOT Stock